Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators.
Arch Pharm (Weinheim)
; 351(3-4): e1700223, 2018 Apr.
Article
in En
| MEDLINE
| ID: mdl-29400412
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazoles
/
Thiazolidinediones
/
PPAR gamma
/
Diabetes Mellitus, Experimental
/
Molecular Docking Simulation
/
Hypoglycemic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Arch Pharm (Weinheim)
Year:
2018
Document type:
Article
Affiliation country:
Country of publication: